5:35 PM
 | 
Jul 01, 2013
 |  BC Extra  |  Politics & Policy

FDA publishes draft guidance on developing antibacterials

FDA published draft guidance on how to streamline clinical trials of therapies for serious bacterial diseases in patients with unmet medical need, including pathogen-focused...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >